Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescentsWALSH, Thomas J; ADAMSON, Peter C; MILLER, Alisha et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 11, pp 4536-4545, issn 0066-4804, 10 p.Article

Assessment of the paradoxical effect of caspofungin in therapy of candidiasisCLEMENS, Karl V; ESPIRITU, Marife; PARMAR, Rachana et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1293-1297, issn 0066-4804, 5 p.Article

Anidulafungin : A novel echinocandinVAZQUEZ, Jose A; SOBEL, Jack D.Clinical infectious diseases. 2006, Vol 43, Num 2, pp 215-222, issn 1058-4838, 8 p.Article

Caspofungin : an advanced treatment approach for suspected or confirmed invasive aspergillosisMAERTENS, Johan.International journal of antimicrobial agents. 2006, Vol 27, Num 6, pp 457-467, issn 0924-8579, 11 p.Article

Efficacy of caspofungin and voriconazole combinations in experimental aspergillosisMACCALLUM, Donna M; WHYTE, Julie A; ODDS, Frank C et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 9, pp 3697-3701, issn 0066-4804, 5 p.Article

Caspofungine, place dans les stratégies thérapeutiques antifongiques = Caspofungin: its place among therapeutic antifungal strategiesLEROY, O; AJANA, F.Antibiotiques (Paris). 2004, Vol 6, Num 2, pp 132-143, issn 1294-5501, 12 p.Article

Efficacy and safety of caspofungin therapy in children with invasive fungal infectionsMERLIN, Etienne; GALAMBRUN, Claire; RIBAUD, Patricia et al.The Pediatric infectious disease journal. 2006, Vol 25, Num 12, pp 1186-1188, issn 0891-3668, 3 p.Article

Efficacy of caspofungin against Aspergillus terreusBARCHIESI, Francesco; SPREGHINI, Elisabetta; MAZZEI, Teresita et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 12, pp 5133-5135, issn 0066-4804, 3 p.Article

Development of Echinocandin Resistance in Clavispora lusitaniae during Caspofungin TreatmentDESNOS-OLLIVIER, Marie; MOQUET, Olivier; CHOUAKI, Taieb et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 6, pp 2304-2306, issn 0095-1137, 3 p.Article

Caspofungin Etest Endpoint for Aspergillus Isolates Shows Poor Agreement with the Reference Minimum Effective ConcentrationFULLER, Jeff; SCHOFIELD, Adam; JIWA, Safeer et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 2, pp 479-482, issn 0095-1137, 4 p.Article

Breakthrough invasive mould infections in patients treated with caspofunginPHAI PANG, Katy-Anna; GODET, Cendrine; DATRY, Annick et al.The Journal of infection. 2012, Vol 64, Num 4, pp 424-429, issn 0163-4453, 6 p.Article

Caspofungin Disk Diffusion Breakpoints and Quality ControlBROWN, Steven D; TRACZEWSKI, Maria M.Journal of clinical microbiology (Print). 2008, Vol 46, Num 6, pp 1927-1929, issn 0095-1137, 3 p.Article

Caspofungin Affects Growth of Paracoccidioides brasiliensis in Both Morphological PhasesRODRIGUEZ-BRITO, Sabrina; NINO-VEGA, Gustavo; SAN-BLAS, Gioconda et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5391-5394, issn 0066-4804, 4 p.Article

A retrospective nationwide case study on the use of a new antifungal agent : patients treated with caspofungin during 2001-2004 in FinlandANTTILA, V.-J; SALONEN, J; YLIPALOSAARI, P et al.Clinical microbiology and infection. 2007, Vol 13, Num 6, pp 606-612, issn 1198-743X, 7 p.Article

Effect of caspofungin on metabolite profiles of Aspergillus species determined by nuclear magnetic resonance spectroscopyPLUMMER, R; BODKIN, J; POWER, D et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 11, pp 4077-4084, issn 0066-4804, 8 p.Article

Efficacy and safety of caspofungin for the empiric management of fever in neutropenic childrenKOO, Alicia; SUNG, Lillian; ALIEN, Upton et al.The Pediatric infectious disease journal. 2007, Vol 26, Num 9, pp 854-856, issn 0891-3668, 3 p.Article

In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolatesMAIDA, C. M; MILICI, M. E; OLIVERI, S et al.Journal of chemotherapy. 2007, Vol 19, Num 3, pp 277-282, issn 1120-009X, 6 p.Article

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients : A prospective, multicenter, observational studySINGH, Nina; LIMAYE, Ajit P; DEL BUSTO, Ramon et al.Transplantation. 2006, Vol 81, Num 3, pp 320-326, issn 0041-1337, 7 p.Article

Caspofungin as treatment for Candida glabrata hip infectionLEJKO-ZUPANC, T; MOZINA, E; VREVC, F et al.International journal of antimicrobial agents. 2005, Vol 25, Num 3, pp 273-274, issn 0924-8579, 2 p.Article

Management of endogenous fungal endophthalmitis with Voriconazole and caspofunginBREIT, Sean M; HARIPRASAD, Seenu M; MIELER, William F et al.American journal of ophthalmology. 2005, Vol 139, Num 1, pp 135-140, issn 0002-9394, 6 p.Article

Paradoxical Growth of Candida dubliniensis Does Not Preclude In Vivo Response to Echinocandin TherapyMARINE, Marçal; JAVIER PASTOR, F; SAHAND, Ismail H et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 12, pp 5297-5299, issn 0066-4804, 3 p.Article

Caspofungin affects adhesion of Candida to a human cell lineKYSELGOF, G; SANDOVSKY-LOSICA, H; BERDICEVSKY, I et al.Journal de mycologie médicale (Paris). 2007, Vol 17, Num 1, pp 1-7, issn 1156-5233, 7 p.Article

Caspofungin in combination with amphotericin B against candida parapsilosisBARCHIESI, Francesco; SPREGHINI, Elisabetta; TOMASSETTI, Serena et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 3, pp 941-945, issn 0066-4804, 5 p.Article

Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosingHOPE, William W; SEIBEL, Nita L; DRUSANO, George L et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 10, pp 3714-3719, issn 0066-4804, 6 p.Article

Efficacy of amphotericin B or amphotericin B : intralipid in combination with caspofungin against experimental aspergillosisSIONOV, Edward; MENDLOVIC, Sonia; SEGAL, Esther et al.The Journal of infection. 2006, Vol 53, Num 2, pp 131-139, issn 0163-4453, 9 p.Article